101股獲社保基金加倉7股持倉市值超10億
格隆匯8月21日丨據證券時報,截至8月20日,已有千餘家上市公司半年報出爐。168家上市公司前十大流通股東中出現社保基金身影,其中101家上市公司獲社保基金新進增持。從持倉市值來看,101家公司中社保基金持倉市值最大的是長春高新,持倉市值在10億元以上的還有雙匯發展、海大集團、我武生物、涪陵榨菜、華魯恆升、安琪酵母等。從持倉比例來看,二季度末,社保基金持倉佔流通股比例在5%以上的有13家公司,持倉比例最高的是我武生物。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.